Trademark: 75025475
Status Date
Thursday, June 8, 2017
Registration Number
2068730
Registration Date
Tuesday, June 10, 1997
Filing Date
Friday, November 17, 1995
Published for Opposition
Tuesday, March 18, 1997
5 pharmaceuticals, namely, pharmaceuticals for use in the treatment of [ cancer ], viral disease and [ inflammatory disease ]
Jun 8, 2017
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jun 8, 2017
Registered And Renewed (Second Renewal - 10 Yrs)
Jun 8, 2017
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jun 6, 2017
Teas Section 8 & 9 Received
Jun 10, 2016
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Feb 10, 2016
Assignment Of Ownership Not Updated Automatically
Jan 27, 2016
Automatic Update Of Assignment Of Ownership
Jun 6, 2007
Teas Change Of Correspondence Received
Dec 5, 2006
Case File In Ticrs
Oct 26, 2006
Registered And Renewed (First Renewal - 10 Yrs)
Oct 26, 2006
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Aug 7, 2006
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Aug 7, 2006
Teas Section 8 & 9 Received
Aug 14, 2003
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 11, 2003
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Jun 10, 2003
Teas Section 8 & 15 Received
Jun 10, 1997
Registered-Principal Register
Mar 18, 1997
Published For Opposition
Feb 14, 1997
Notice Of Publication
Jan 15, 1997
Approved For Pub - Principal Register
Nov 6, 1996
Correspondence Received In Law Office
May 30, 1996
Non-Final Action Mailed
May 14, 1996
Assigned To Examiner
May 13, 1996
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
